
Health-related quality of life (HRQoL) in kidney transplant recipients (KTRs) is a key concern influenced by physiological, social, and cultural factors. However, yet commonly used assessment tools in previous studies do not adequately capture the unique sociocultural context of Chinese populations....

Hematopoietic stem cell transplant (HSCT) is a well-established procedure for malignant and nonmalignant conditions. Despite its therapeutic benefits, kidney disease remains a common complication that significantly affects patient outcomes. Kidney injury post-HSCT manifests as acute kidney injury and...

In real-world management and research of kidney transplantation(KT), critical evidence has long evolved along two parallel tracks: structured longitudinal follow-up and text-defined rules. On the one hand, OPTN and SRTR collect Transplant Recipient Follow-up (TRF) at 6 months post transplant, at 1 year,...

Regulatory T cells (Tregs) play a pivotal role as key modulators of immune tolerance in kidney transplantation, a critical therapeutic approach for end-stage renal disease. Despite advances in surgical techniques and immunosuppressive regimens, kidney transplantation continues to face significant challenges,...

Autosomal dominant hypocalcaemia (ADH) is a rare abnormality of calcium homeostasis. It is usually associated with gain-of-function mutations in the calcium sensing receptor (CaSR, ADH1) or its associated G-protein (GNA11, autosomal dominant hypocalcaemia type 2 [ADH2]). The CaSR is expressed in several...